SEC Form 4 · accession 0001683168-18-000070

Dougherty's Pharmacy, Inc. · MYDP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 27, 2017

Accepted (ET)

Jan 8, 2018 · 4:28 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001080029

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jan 1, 2018	M	5,100	—	A	1,630,740	D
Common Stock^F2	Dec 27, 2017	J	32,513	—	A	1,666,253	D
Common Stock^F2,F3	Dec 27, 2017	J	3,099	—	A	1,666,253	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F4,F5,F6	—	Jan 1, 2018	M	5,100	D	—	—	Common Stock	5,100	30,350	D
Restricted Stock Units^F5,F6	—	Jan 1, 2018	M	20,000	A	—	—	Common Stock	20,000	50,350	D
Restricted Stock Units^F4,F6	—	Dec 27, 2017	J	600	A	—	—	Common Stock	600	50,950	D

F1Acquired pursuant to automatic vesting of Restricted Stock Units issued under the Issuer's Restricted Share Unit Incentive Plan.
F2Acquired pursuant to the Issuer's declaration of a common stock dividend effective as of December 27, 2017.
F3Comprised of 1,554 shares held in trust for the benefit of James Josiah Leslie, and 1,545 shares held in trust for the benefit of Jenna L. Leslie. Mr. Leslie disclaims beneficial ownership for all of these 3,099 shares.
F4Issued under the Issuer's Restricted Share Unit Incentive Plan.
F5Converted pursuant to automatic vesting of Restricted Stock Units issued under the Issuer's Restricted Share Unit Incentive Plan.
F6Restricted Stock Units vest periodically through January 1, 2022.